NASDAQ:INMB

Inmune Stock Predictions

Healthcare > Biotechnology

Buy INMB

*Your capital is at risk

$1.42

-0.0700 (-4.70%)

At Close: Jun 26, 2026

Currently predicting for Mon, 29 Jun 2026

INMB Live board

Community Bull/Bear

Target Next close

Join the INMB prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

INMB Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For INMB

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

INMB Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT INMUNE BIO INC.

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
JLL $299.78	5.10%	Jun 24
NMRK $15.02	1.66%	Jun 24
X XMAX $8.34	5.40%	Jun 24
NESR $25.07	12.64%	Jun 23
TTEK $28.04	4.35%	Jun 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by